Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • E-News Sign Up
  • My Cart
  • Transplant Indications and Outcomes
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • MDS
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • HLA Today
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Research and News
    • Browse Research
      • Pre-transplant blinatumomab reduces MRD, time to HCT for pediatric patients with B-ALL
      • Novel cytogenetic-based risk scores predict HCT outcomes for patients with CLL
    • Browse News
    • About Our Research
    • Transplant Enews
      • Advances in Transplant Enews
      • Resource Connection Enews
  • Resources and Education
    • HCT Presentation Slides
      • Hemaglobinopathies, Transplant Consultation Timing Guidelines
      • Myeloproliferative Neoplasms (MPN), Transplant Consultation Timing Guidelines
    • Patient Resources
    • Financial Resources
    • Materials Catalog
    • Obstetrician Resources
    • Education Catalog
      • Sickle Cell Disease: Exploring treatment options and psychosocial care
      • Continuing Education Discontinuation
      • Building Yourself From The Ground Up
    • Technique Video
    • Umbilical Cord Blood Collection Training for Public Donation
  • Cell Sources
  • HLA Typing and Matching
  • Donor or Cord Blood Search Process
  • Jason Carter Clinical Trials Program

Donor or Cord Blood Search Process

  • Likelihood of Finding a Match
  • Preliminary Search Request
  • Transplant Therapy and Donor Matching
  • Donor or Cord Blood Search Process
  • Likelihood of Finding a Match
  • Email
  • Print This Page

Related Resources

  • Preliminary Search Request Form
  • Transplant Outcomes Fact Sheet (PDF)

Likelihood of Finding a Match for Patients

Seven of ten patients in need of hematopoietic cell transplantation (HCT) do not have a human leukocyte antigen (HLA) fully matched family donor and need a transplant using an unrelated donor or cord blood unit (CBU) on an unrelated donor registry such as the Be The Match Registry®.

Because of the continuing growth and increasing ethnic diversity of the Be The Match Registry, an overwhelming percentage of patients who need an unrelated donor transplant will have a suitably matched, available donor or a CBU with an adequate cell dose on the Be The Match Registry. A 2014 study found that depending on a searching patient's ethnic background, this match likelihood is between 91-99%. [1]

Likelihood of Finding a Match

The 2014 study used population-based genetic models for 21 ethnic groups, and Figures 1-5 below show the likelihood of a match for searching patients in these 21 groups. A suitably matched adult donor is defined as one matched with the patient at ≥7/8 HLA loci (HLA-A, -B, -C, and -DRB1). Due to the less stringent HLA matching requirements of cord blood, a suitably matched CBU is defined as one matched with the patient at ≥4/6 HLA loci (HLA-A, -B, and -DRB1)

Figure 1. Likelihood of Finding a Matching Available Adult Donor, by Ethnic Background

Likelihood of Finding a Matching Available Adult Donor, by Ethnic Background

Download slide


Figure 2. Likelihood of Finding a Matching CBU with Adequate Cell Dose, Patients ≥20 Years, by Ethnic Background

Likelihood of Finding a Matching CBU with Adequate Cell Dose, Patients ≥20 Years, by Ethnic Background

Download slide


Figure 3. Likelihood of Finding a Matching CBU with Adequate Cell Dose, Patients <20 Years, by Ethnic Background

Likelihood of Finding a Matching CBU with Adequate Cell Dose, Patients <20 Years, by Ethnic Background

Download slide


Figure 4. Likelihood of Finding a Matching Available Adult Donor or CBU with Adequate Cell Dose, Patients <20 Years, by Ethnic Background

Likelihood of Finding a Matching Adult Donor, by Ethnic Background

Download slide


Figure 5. Likelihood of Finding a Matching Available Adult Donor or CBU with Adequate Cell Dose, Patients ≥20 Years, by Ethnic Background

Likelihood of Finding a Matching Available Adult Donor or CBU with Adequate Cell Dose, Patients ≥20 Years, by Ethnic Background

Download slide

Growth of the Be The Match Registry

A patient's likelihood of finding a potential unrelated donor or CBU has increased with the continuing growth and increasing ethnic diversity of the Be The Match Registry, which includes nearly 12.5 million potential adult donors (marrow or peripheral blood stem cells) and more than 209,000 CBUs. And through our international connections, NMDP/Be The Match searches more than 24.5 million potential donors and more than 622,000 CBUs.

Figure 6. Growth of the Donor Registry

Growth of the Donor Registry

Download slide

Figure 7. Growth of the Cord Blood Registry

Growth of the Cord Blood Registry

Download slide

Reference

  1. Gragert L, Eapen M, Williams E, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014; 371(4): 339-348. Access
  • Email
  • Print This Page

Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

Transplant Indications and Outcomes

  • Disease-Specific Indications and Outcomes
  • Additional Outcomes
  • Eligibility
  • Referral Timing Guidelines
  • HLA Today

Transplant Therapy and Donor Matching

  • Cell Sources
  • HLA Typing and Matching
  • Donor or Cord Blood Search Process
  • Jason Carter Clinical Trials Program

Resources and Education

  • HCT Presentation Slides
  • Patient Resources
  • Financial Resources
  • Materials Catalog
  • Obstetrician Resources
  • Education Catalog
  • Technique Video
  • Umbilical Cord Blood Collection Training for Public Donation

Contact Us

About Us

Our Websites

bethematch.org
BeTheMatch.org Information and support for patients, donors and supporters of our mission.
BeTheMatchBioTherapies.com
BeTheMatchBioTherapies.com Proven solutions for organizations developing and delivering new cellular therapies
CIBMTR.org
CIBMTR.org Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2021 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright